John J. Alam, EVP, Medicines Development & CMO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 480 shares at $25.41 ($12K) on 2007-12-11, disclosed to the SEC on 2007-12-12.
Scheduled sale ($12k) by EVP, Medicines Development & CMO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.41 | 50 | $1K | 10.3% |
| 2 | $25.52 | 50 | $1K | 10.4% |
| 3 | $25.57 | 50 | $1K | 10.4% |
| 4 | $25.58 | 50 | $1K | 10.4% |
| 5 | $25.59 | 140 | $4K | 29.1% |
| 6 | $25.60 | 45 |
| $1K |
| 9.4% |
| 7 | $25.82 | 50 | $1K | 10.5% |
| 8 | $25.96 | 45 | $1K | 9.5% |
| Total | $25.62 avg | 480 | $12K | 100% |
| Filing → |
| CRVO | BUY | 2025-11-13 | $41K | — | Filing → |
| VRTX | SELL | 2008-10-02 | $139K | — | Filing → |
| VRTX | SELL | 2008-09-11 | $173K | — | Filing → |